Year 2018 / Volume 110 / Number 9
Editorial
Protecting renal function: a relevant decision for liver transplantation

535-537

DOI: 10.17235/reed.2018.5836/2018

José Antonio Pons Miñano,

Abstract
Advances in surgical technique, as well as in medical management and immunosuppression (IS), have represented a significant improvement in the survival of patients undergoing liver transplantation (LT), with 1-year, 5-year, and 10-year survival rates of 86%, 73%, and 62%, respectively, according to the Spanish liver transplant registry.
Share Button
New comment
Comments
No comments for this article
References
1. http://www.sethepatico.org/docs/2016/MEMORIA_RETH_2016_GENERAL. (Consultado 10 de Julio de 2018).
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
3. Fellström B, Jardine AG, Soveri I, et al. Renal dysfunction is a strong and independent risk factor for maortality and cardiovscular complications in renal transplantation. Am J Transplant 2005;5:1986-91
4. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-40.
5. Al Riyami D, Alam A, Badovinac K, et al. Decreases survival in liver transplant patients requiring chronic dialysis: a Canadian experience. Transplantation 2008;85:1277-80
6. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy. Risk of development and treatment. Transplantation 2001;72:1934-9
7. Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010;10:1420-7
8. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl. 2003;9:741-7.
9. Herrero JI, Cuervas-Mons V, Gomez-Bravo MA, et al. Prevalence and progression of chronic kidney disease after a liver transplant: a prospective, real-life, observational, two- year multicenter study Rev Esp Enerm Dig 2018. doi: 10.17235/reed.2018.5431/2017.
10. Allen AM, Kim R, Therneau TM, et al. Chronic Kidney Disease and Associated Mortality after Liver Transplantation – a Time-Dependent Analysis Using Measured Glomerular Filtration Rate. J Hepatol 2014;61:286-92
11. Bloom RD, Reese PP. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol. 2007;18:3031-41.
12. Cabezuelo JB, Ramirez P, Rios A, et al. Risk factors of acute renal failure after liver transplantation. Kidney Int 2006;69:1073-80.
13. Pillebout E, Nochy D, Hill G, et al. Renal histopathology lesions after orthotopic liver transplantation. Am J Transplant 2005;5:1120-29
14. Kim JY, Akalin E, Dikman S, et al. The variable pathology of kidney disease after liver transplantation. Transplantation. 2010;89:215-21.
15. Rodriguez-Perálvarez M, Germani T, Darius J, et al. Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta-Analysis. Am J Transplant 2012;12:2797-814.
16. Neuberger JM, Bechstein WO, Kuypers DR, et al. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation(COMMIT) Group. Transplantation. 2017;101(4S Suppl 2):S1-S56.
17. Londoño MC, Rimola A, O’Grady J, et al. Immunosuppression minimization vs. Complkete withdrawal in liver transplantation. J Hepatol 2013;59:872-79.
18. TruneČka P, Klempnauer J, Bechstein WO, et al. Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. Am J Transplant. 2015;15:1843-54.
19. Herrero JI, Quiroga J, Sangro B, et al. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. Liver Transpl Surg. 1999 ;5:414-20.
20. De Simone P, Metselaar HJ, Fischer L, et al. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: prospective, randomized, multicenter trial. Liver Transpl. 2009;15:1262-9.
21. Pons JA, Ramírez P, Revilla-Nuin B, et al. Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients. Clin Transplant. 2009 ;23:329-36.
22. Créput C, Blandin F, Deroure B, et al. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transpl. 2007 ;13:1004-10.
23. Aguiar D, Martínez-Urbistondo D, Baroja-Mazo A, et al. Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients. Ann Transplant. 2017;22:265-275
Related articles

Digestive Diseases Image

Posterior reversible encephalopathy syndrome (PRES) in post liver transplantation

DOI: 10.17235/reed.2022.8694/2022

Letter

Ertapenem neurotoxicity in liver transplantation

DOI: 10.17235/reed.2021.8469/2021

Digestive Diseases Image

Percutaneous treatment of a splenorenal shunt with an atrial septal closure device

DOI: 10.17235/reed.2020.7701/2020

Review

Physical frailty in liver transplantation

DOI: 10.17235/reed.2020.7448/2020

Letter

Management of hepatic artery aneurysms

DOI: 10.17235/reed.2020.7219/2020

Digestive Diseases Image

Epithelioid hemangioendothelioma: a rare cause of a liver tumor

DOI: 10.17235/reed.2020.7127/2020

Letter to the Editor

Post-transplant lymphoproliferative disease after liver transplantation

DOI: 10.17235/reed.2017.5387/2017

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Citation tools
Pons Miñano J. Protecting renal function: a relevant decision for liver transplantation. 5836/2018


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 786 visits.
This article has been downloaded 118 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 21/07/2018

Accepted: 23/07/2018

Online First: 31/07/2018

Published: 31/08/2018

Article Online First time: 10 days

Article editing time: 41 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology